Targeting STAT3 in Cancer Immunotherapy
Abstract As a point of convergence for numerous oncogenic signaling pathways, signal transducer and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune response. STAT3 is broadly hyperactivated both in cancer and non-cancerous cells within the tumor ecosystem and play...
Main Authors: | Sailan Zou, Qiyu Tong, Bowen Liu, Wei Huang, Yan Tian, Xianghui Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-020-01258-7 |
Similar Items
-
Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy
by: Mara De Martino, et al.
Published: (2020-01-01) -
Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01) -
Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy
by: Kelly eKersten, et al.
Published: (2015-10-01) -
New developments in immunotherapy for lymphoma
by: Benjamin Heyman, et al.
Published: (2018-09-01) -
The age of enlightenment in melanoma immunotherapy
by: Mark R. Albertini
Published: (2018-08-01)